Malaysian Cocoa Journal Header
Volume 18 2026

COCOA (THEOBROMA CACAO) AS A NATURAL THERAPEUTIC AGENT FOR WOUND HEALING: A COMPREHENSIVE REVIEW

Authors

Md Yusof, AH.1*, Abdul Hamid, H2, Abd Gani S. S. 2, Muslim, M.B.1

ABSTRACT

Wound healing is a complex biological process involving hemostasis, inflammation, proliferation, and tissue remodeling. Despite advances in wound management, chronic wounds remain a significant clinical challenge due to persistent inflammation, oxidative stress, microbial infection, and impaired tissue regeneration. Consequently, increasing interest has focused on plant-derived bioactive compounds as potential multifunctional therapeutic agents. Among these, Theobroma cacao L. has emerged as a promising natural resource because of its rich phytochemical composition, including flavanols, procyanidins, phenolic acids, methylxanthines, polysaccharides, fatty acids, vitamins, and minerals. These bioactive compounds exhibit antioxidant, anti inflammatory, antimicrobial, angiogenic, and collagen-stimulating properties that collectively support tissue repair. This review summarizes the phytochemical composition of T. Cacao, its mechanisms of action, and current evidence supporting its wound-healing potential. In vitro, studies demonstrate that cocoa-derived compounds reduce oxidative stress, enhance fibroblast viability, stimulate collagen synthesis, and improve keratinocyte function. Animal studies further show accelerated wound closure, enhanced re-epithelialization, and improved tissue organization following topical application of cocoa extracts. Clinical studies, although limited, suggest beneficial effects on skin elasticity, hydration, and collagen metabolism. The review also highlights the emerging use of cocoa pod husks as sustainable sources of bioactive pectin for hydrogels, tissue engineering, and advanced wound dressings. Overall, current evidence supports T. cacao as a potential multifunctional natural therapeutic agent for wound healing, although standardized formulations and well-designed clinical trials are required before widespread clinical application.
VIEW PDF DOWNLOAD